219 related articles for article (PubMed ID: 34441310)
1. Comparative Study on Epstein-Barr Virus-Positive Mucocutaneous Ulcer and Methotrexate-Associated Lymphoproliferative Disorders Developed in the Oral Mucosa: A Case Series of 10 Patients and Literature Review.
Obata K; Okui T; Ono S; Umemori K; Ryumon S; Ono K; Yao M; Yoshioka N; Ibaragi S; Sasaki A
Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441310
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
3. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
[TBL] [Abstract][Full Text] [Related]
4. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
Satou A; Banno S; Kohno K; Takahara T; Takahashi E; Nobata H; Iwagaitsu S; Watanabe D; Hanamura I; Takami A; Ito Y; Nakamura S; Tsuzuki T
Pathology; 2021 Aug; 53(5):595-601. PubMed ID: 33618861
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
[TBL] [Abstract][Full Text] [Related]
7. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
Satou A; Banno S; Hanamura I; Takahashi E; Takahara T; Nobata H; Katsuno T; Takami A; Ito Y; Ueda R; Nakamura S; Tsuzuki T
Pathol Int; 2019 Jan; 69(1):21-28. PubMed ID: 30615240
[TBL] [Abstract][Full Text] [Related]
8. Successful Treatment of Intracranial Methotrexate-associated Lymphoproliferative Disorder without Epstein-Barr Virus Infection Using Rituximab, Methotrexate, Procarbazine, and Vincristine: A Case Report.
Mizushima M; Ishi Y; Ikeda H; Echizenya I; Otsuka T; Mitsuhashi T; Yamaguchi S; Fujimura M
NMC Case Rep J; 2022; 9():237-242. PubMed ID: 36061907
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.
Shiraiwa S; Kikuti YY; Carreras J; Hara R; Aoyama Y; Ogiya D; Suzuki R; Toyosaki M; Ohmachi K; Ogawa Y; Kawada H; Sato S; Nakamura N; Ando K
J Clin Exp Hematop; 2020 Dec; 60(4):159-168. PubMed ID: 33148934
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Kitamura N; Sugiyama K; Nagasawa Y; Hamaguchi M; Kobayashi H; Takei M
Clin Exp Rheumatol; 2022 Jul; 40(7):1330-1335. PubMed ID: 34369356
[TBL] [Abstract][Full Text] [Related]
12. A rare case of Epstein-Barr virus-positive mucocutaneous ulcer that developed into an intestinal obstruction: a case report.
Morita N; Okuse C; Suetani K; Nakano H; Hiraishi T; Ishigooka S; Mori S; Shimamura T; Asakura T; Koike J; Itoh F; Suzuki M
BMC Gastroenterol; 2020 Jan; 20(1):9. PubMed ID: 31931725
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
14. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
15. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
18. The first case of methotrexate-associated lymphoproliferative disorder in the sacrum: a case report.
Yamaguchi Y; Morimoto T; Toda Y; Tsukamoto M; Yoshihara T; Hirata H; Kobayashi T; Mawatari M
BJR Case Rep; 2024 Jan; 10(1):uaae002. PubMed ID: 38352263
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature.
Ravi PY; Sigamani E; Jeelani Y; Manipadam MT
Indian J Pathol Microbiol; 2018; 61(2):255-257. PubMed ID: 29676371
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]